首页> 外文期刊>Modern Pathology >Monoclonal Antibody Specific for Histone H1 Phosphorylated by Cyclin-Dependent Kinases: A Novel Immunohistochemical Probe of Proliferation and Neoplasia
【24h】

Monoclonal Antibody Specific for Histone H1 Phosphorylated by Cyclin-Dependent Kinases: A Novel Immunohistochemical Probe of Proliferation and Neoplasia

机译:细胞周期蛋白依赖性激酶磷酸化的组蛋白H1特异性的单克隆抗体:增殖和瘤形成的新型免疫组织化学探针。

获取原文
           

摘要

Monoclonal antibody 12D11 (MAb 12D11) has been shown to bind histone H1 isolated from human placenta and other tissues but not histone H1 that has been digested with bacterial alkaline phosphatase. We show here that phosphorylation of phosphatase-treated histone H1 with cyclin dependent-kinase (CDK) restores binding by MAb 12D11. We conclude that MAb 12D11 selectively binds histone H1 that has been phosphorylated by CDKs, and we have investigated the use of MAb 12D11 as an immunohistochemical probe of CDK activity in situ. Previous immunofluorescence studies have revealed strong nuclear staining by MAb 12D11 in proliferating cultured cells and the absence of staining in terminally differentiated cells. Immunohistochemical staining of frozen and formalin-fixed, paraffin-embedded sections of benign tissues with MAb 12D11 was nuclear and confined to recognized foci of cell proliferation. In lymphoid germinal centers, MAb 12D11 preferentially stained large lymphoid cells with a relative lack of staining in small cleaved cells, contrasting with a lack of cell size discrimination observed with the monoclonal antibody proliferation probe, MIB-1. Tumor tissues displayed strong albeit heterogeneous staining of malignant cells by MAb 12D11, with little or no staining observed in surrounding nonneoplastic stromal cells. Differential staining by MAb 12D11 of invasive and in situ carcinoma suggest applications in prognostication. MAb 12D11 may also be useful in identification of tumors more likely to respond to therapeutic CDK inhibitors.
机译:已显示单克隆抗体12D11(MAb 12D11)结合从人胎盘和其他组织分离的组蛋白H1,但不结合已被细菌碱性磷酸酶消化的组蛋白H1。我们在此处显示,用细胞周期蛋白依赖性激酶(CDK)磷酸酶处理的组蛋白H1的磷酸化可恢复单克隆抗体12D11的结合。我们得出的结论是,单克隆抗体12D11选择性结合已被CDK磷酸化的组蛋白H1,我们已经研究了单克隆抗体12D11作为CDK活性的免疫组织化学探针的用途。先前的免疫荧光研究表明,MAb 12D11在增殖的培养细胞中具有强烈的核染色,而在终末分化的细胞中则没有染色。用MAb 12D11对良性组织的冷冻和福尔马林固定,石蜡包埋的切片的免疫组织化学染色是核的,并局限于公认的细胞增殖灶。在淋巴样生发中心,MAb 12D11优先对大淋巴样细胞染色,而在小裂解细胞中则相对缺乏染色,这与用单克隆抗体增殖探针MIB-1观察到的细胞大小识别缺乏对比。肿瘤组织显示出尽管MAb 12D11对恶性细胞有很强的异质染色,但在周围的非肿瘤基质细胞中却很少或没有染色。侵袭性和原位癌的MAb 12D11差异染色提示其在预后中的应用。 MAb 12D11也可能用于鉴定更可能对治疗性CDK抑制剂起反应的肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号